Basic Information
Amulet Pharmaceuticals uses their NORTECH™ technology to discover and develop novel therapies addressing unmet needs in large markets with known current treatments. Their lead program (AMU-301) targets diabetic gastroparesis, an unmet complication of diabetes.
Amulet Pharmaceuticals Inc.
Maryland,United States of America
15~50 people
January 01, 2006
--
info@amuletpharma.com